T1	Participants 483 502	Ninety-two patients
T2	Participants 363 371	patients
T3	Participants 1084 1140	Of the 92 randomized patients, 70 patients were analyzed
T4	Participants 1154 1162	patients
T5	Participants 1182 1190	Patients
T6	Participants 1961 1969	patients
T7	Participants 1728 1736	patients
T8	Participants 1830 1836	groups
T9	Participants 927 936	patients.
